TY - UNPB
T1 - Population-based Risk of Psychiatric Disorders Associated with Recurrent CNVs
AU - Vaez, Morteza
AU - Montalbano, Simone
AU - Sánchez, Xabier Calle
AU - Georgii Hellberg, Kajsa-Lotta
AU - Rasekhi Dehkordi, Saeid
AU - Dybdahl Krebs, Morten
AU - Meijsen, Joeri
AU - Shorter, John
AU - Byberg-Grauholm, Jonas
AU - Mortensen, Preben B
AU - Børglum, Anders D
AU - Hougaard, David M
AU - Nordentoft, Merete
AU - Geschwind, Daniel H
AU - Buil, Alfonso
AU - Schork, Andrew J
AU - Helenius, Dorte
AU - Raznahan, Armin
AU - Thompson, Wesley K
AU - Werge, Thomas
AU - Ingason, Andrés
AU - iPSYCH Investigators
PY - 2023/9/5
Y1 - 2023/9/5
N2 - Recurrent copy number variants (rCNVs) are associated with increased risk of neuropsychiatric disorders but their pathogenic population-level impact is unknown. We provide population-based estimates of rCNV-associated risk of neuropsychiatric disorders for 34 rCNVs in the iPSYCH2015 case-cohort sample (n=120,247). Most observed significant increases in rCNV-associated risk for ADHD, autism or schizophrenia were moderate (HR:1.42-5.00), and risk estimates were highly correlated across these disorders, the most notable exception being high autism-associated risk with Prader-Willi/Angelman Syndrome duplications (HR=20.8). No rCNV was associated with significant increase in depression risk. Also, rCNV-associated risk was positively correlated with locus size and gene constraint. Comparison with published rCNV studies suggests that prevalence of some rCNVs is higher, and risk of psychiatric disorders lower, than previously estimated. In an era where genetics is increasingly being clinically applied, our results highlight the importance of population-based risk estimates for genetics-based predictions.
AB - Recurrent copy number variants (rCNVs) are associated with increased risk of neuropsychiatric disorders but their pathogenic population-level impact is unknown. We provide population-based estimates of rCNV-associated risk of neuropsychiatric disorders for 34 rCNVs in the iPSYCH2015 case-cohort sample (n=120,247). Most observed significant increases in rCNV-associated risk for ADHD, autism or schizophrenia were moderate (HR:1.42-5.00), and risk estimates were highly correlated across these disorders, the most notable exception being high autism-associated risk with Prader-Willi/Angelman Syndrome duplications (HR=20.8). No rCNV was associated with significant increase in depression risk. Also, rCNV-associated risk was positively correlated with locus size and gene constraint. Comparison with published rCNV studies suggests that prevalence of some rCNVs is higher, and risk of psychiatric disorders lower, than previously estimated. In an era where genetics is increasingly being clinically applied, our results highlight the importance of population-based risk estimates for genetics-based predictions.
U2 - 10.1101/2023.09.04.23294975
DO - 10.1101/2023.09.04.23294975
M3 - Preprint
C2 - 37886536
T3 - medRxiv : the preprint server for health sciences
BT - Population-based Risk of Psychiatric Disorders Associated with Recurrent CNVs
ER -